Testing effectiveness (Phase 2)WithdrawnNCT00003984
What this trial is testing
Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome
Who this might be right for
Myelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC